Why Is Pylera So Hard to Find? [Explained for 2026]

You've been diagnosed with an H. pylori infection. Your doctor wrote a prescription for Pylera — the combination capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline. You head to your local pharmacy, and they tell you they don't have it. You call three more pharmacies. Same story. What's going on?

Despite not appearing on the FDA's official drug shortage list, Pylera can be genuinely difficult to track down at pharmacies across the United States in 2026. The reasons are more complicated than a simple supply problem — and understanding them can help you find your medication faster.

Is Pylera Currently in Shortage?

Technically, no. As of 2026, Pylera (bismuth subcitrate potassium/metronidazole/tetracycline) is not listed on the FDA's official Drug Shortages Database. That means the manufacturer is not reporting a production or supply disruption to the FDA. However, the FDA's shortage list only captures officially reported shortages — it doesn't tell you what's sitting on the shelves at your local CVS or Walgreens.

Many patients and prescribers report difficulty finding Pylera in stock, especially at smaller independent pharmacies and certain chain locations. The reasons behind this are largely economic and logistical, rather than a manufacturing crisis.

Why Don't Pharmacies Stock Pylera?

Pylera is a specialty medication used for a specific indication — eradicating Helicobacter pylori bacteria in patients with duodenal ulcers. This means it's prescribed far less often than common medications like blood pressure drugs or antibiotics for respiratory infections. When a medication is prescribed infrequently, pharmacies must weigh the cost of keeping it on their shelves against the likelihood that a patient will need it.

Here are the main reasons Pylera is hard to find at pharmacies:

High cost deters stocking. The retail price of Pylera is approximately $300–$400 for a 10-day course (120 capsules). Pharmacies that stock it risk having expensive inventory sitting on the shelf for months if demand is low.

Low prescription volume. H. pylori is a relatively common infection (affecting roughly 30-40% of the U.S. population at some point), but Pylera is not the only treatment option. Many gastroenterologists and primary care doctors prescribe the same active ingredients separately, or use alternative regimens, reducing demand for the branded Pylera capsule.

Insurance coverage gaps. Many insurance plans, including some Medicare Part D plans and Medicaid programs, do not cover Pylera or place it on high-cost tiers. When patients can't afford the out-of-pocket cost, pharmacies have fewer reasons to keep large quantities in stock.

Limited distribution footprint. Pylera is currently manufactured by H2 Pharma. Compared to blockbuster drugs produced by multiple manufacturers, the distribution network for Pylera is narrower, which can create regional gaps in availability.

Generic uncertainty. While the FDA has approved a generic version of Pylera (bismuth subcitrate potassium/metronidazole/tetracycline combination capsule), generic availability at pharmacies can be inconsistent. The three active ingredients are available generically as separate drugs, but the all-in-one capsule format is not universally stocked.

What Makes Pylera Different From Other Antibiotics?

Pylera isn't just an antibiotic — it's a triple-drug combination in a single capsule. Each Pylera capsule contains bismuth subcitrate potassium (140 mg), metronidazole (125 mg), and tetracycline hydrochloride (125 mg). Patients take 3 capsules four times per day for 10 days, alongside omeprazole, for a total of 120 capsules over the course of treatment.

This complexity is intentional — combining three drugs that attack H. pylori through different mechanisms helps overcome antibiotic resistance. Bismuth disrupts the bacteria's outer membrane, metronidazole damages its DNA, and tetracycline blocks protein synthesis. But that same complexity makes the drug more specialized, more expensive to manufacture, and harder to source compared to single-ingredient antibiotics.

Does Insurance Cover Pylera?

Coverage is inconsistent. Some commercial insurance plans (including certain plans from Humana, United Healthcare, and Kaiser Permanente) do cover Pylera, typically placing it on a higher formulary tier. Many plans require prior authorization before they'll cover it. Medicare Part D plans vary widely — some cover it, others don't. Medicaid coverage for Pylera is limited in most states.

Without insurance, the retail price ranges from roughly $300 to $400 per course at major pharmacy chains. Using GoodRx or SingleCare discount cards can bring the price down to approximately $187–$200 for a 10-day supply. Patient assistance programs are also available for patients who qualify based on income.

Can't I Just Get the Individual Ingredients Separately?

Yes — and this is actually a common and effective workaround. Your doctor can prescribe bismuth subsalicylate (a form of bismuth available over the counter in products like Pepto-Bismol), metronidazole, and tetracycline as separate generic medications, along with a proton pump inhibitor like omeprazole. This "traditional" bismuth quadruple therapy achieves similar H. pylori eradication rates as Pylera, though it means taking more separate pills each day.

The individual generic components are typically far less expensive and more widely available than the combined Pylera capsule. Talk to your doctor or pharmacist about whether this option makes sense for you.

What Should I Do If I Can't Find Pylera?

Here are your best next steps if your pharmacy doesn't have Pylera in stock:

Use medfinder to locate nearby pharmacies. medfinder contacts pharmacies near you to check which ones can fill your Pylera prescription right now, saving you hours of phone calls.

Call larger chain pharmacies. CVS, Walgreens, and large grocery store pharmacies are more likely to stock Pylera than smaller independent pharmacies. Hospital-affiliated outpatient pharmacies can also be a good option.

Ask your doctor about alternatives. If Pylera is genuinely unavailable or unaffordable, your doctor may be able to prescribe the same active ingredients as separate generics, or consider an alternative H. pylori regimen. See our full guide to Pylera alternatives for more options.

Try mail-order pharmacies. If you have insurance, your plan may offer 90-day fills through a mail-order pharmacy at lower cost. For brand-name prescriptions, this can also improve availability.

Use a prescription discount card. GoodRx and SingleCare coupons can reduce the out-of-pocket cost to approximately $187–$200, which may make it more likely your pharmacy is willing to order a supply.

Is H. pylori Treatment Urgent?

Yes. While H. pylori infections are not immediately life-threatening for most patients, untreated H. pylori is linked to peptic ulcers, gastritis, and in some cases, an increased risk of gastric cancer. The ACG (American College of Gastroenterology) recommends that all confirmed H. pylori infections be treated. Delaying treatment to save money or because of availability issues can lead to complications that are harder — and more expensive — to treat later.

If you can't find Pylera today, contact your prescribing doctor. They can help you pivot to an equally effective alternative regimen rather than waiting indefinitely. For more tips on tracking down Pylera near you, see our guide on how to find Pylera in stock.